:no_upscale()/cdn.vox-cdn.com/uploads/chorus_image/image/60457727/CRISPR_LEAD.0.jpg "CRISPR, one of the biggest science stories of the decade, explained - Vox")
CRISPR, one of the biggest science stories of the decade, explained - Vox
Is Crispr the Next Antibiotic? - The New York Times
CRISPR-engineered T cells in patients with refractory cancer | Science
CRISPR: gene editing is just the beginning : Nature News & Comment
Focus on CRISPR tools and therapies | Nature Biotechnology
Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research: Molecular Therapy - Methods & Clinical Development
CRISPR gene editing - Wikipedia
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects | Signal Transduction and Targeted Therapy
Nature Medicine on Twitter: "Two studies find that #AAV-mediated #CRISPR/ Cas9 therapy extends life span and ameliorates disease-related phenotypes in a mouse model of #progeria. https://t.co/2LfOogSXLX and https://t.co/y5KjuD5Yjb… https://t.co/RMaa25wQoI"
Developing CRISPR/CAS9 technologies for research and medicine - MedCrave online
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells | Nature Medicine
CRISPR-Cas 9 corrects genetic defects in mice
The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology
Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome. - Nat. Med. - X-MOL
Nature Medicine - About the cover: Using CRISPR-Cas9–based genome editing technology, Sato and colleagues (featured on p 256 of this month's issue) introduce various combinations of mutations associated with human intestinal tumors
CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review
CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology | npj Precision Oncology
Four U.S. CRISPR Trials Editing Human DNA to Research New Treatments | Science | Smithsonian Magazine
CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response | Nature Medicine
CRISPR-Edited Cells Linked to Cancer Risk in 2 Studies - Scientific American
CRISPR, the disruptor : Nature News & Comment
